Asia Pacific Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component, Type, Extremity, Application, Mobility, and End Users

List of Tables

The Asia Pacific medical exoskeleton market was valued at US$ 76.43 million in 2023 and is expected to reach US$ 720.20 million by 2031; it is estimated to register a CAGR of 32.4% from 2023 to 2031.

Increasing Prevalence of SCI Boosts Asia Pacific Medical Exoskeleton Market

Reduced physical activity and the predominance of seated activities can lead to severe physical and psychological deterioration in people suffering from SCI. Secondary complications related to SCI can also reduce life expectancies. According to the National Library of Medicine, nearly 250,000-500,000 patients suffer from SCIs every year worldwide. An elevated number of cases is attributed to motocross and motorcycling competitions emerging as the most popular sporting activities worldwide, as per the National Institute of Health report. According to the WHO, globally, ~1.19 million people die every year in road crashes, and 20-50 million people suffer non-fatal injuries, with many incurring disabilities. Companies such as Lifeward are focusing on developing exoskeletons that help patients with SCI perform physical activities without pain. For instance, about 20% of the SCI population can be considered candidates for clinical trials of the current ReWalk Personal Exoskeleton or ReWalk Rehabilitation Exoskeleton. Moreover, soft exo-suit devices in medical exoskeletons can be used for patients suffering from SCI. Thus, the increase in the prevalence of SCI and ongoing research for the use of exoskeletons for SCI patients can be expected to fuel the market growth during the forecast period.

Asia Pacific Medical Exoskeleton Market Overview

The medical exoskeleton market in Asia Pacific is sub segmented into Malaysia, Thailand, India, Singapore, the Philippines, Vietnam, Indonesia, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Rising geriatric population, increasing chronic diseases, growing technological advancements, and surging number of startups are the factors favoring the market progress in this region.

Asia Pacific Medical Exoskeleton Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Medical Exoskeleton Market Segmentation

The Asia Pacific medical exoskeleton market is categorized into component, type, extremity, application, mobility, end users, and country.

By component, the Asia Pacific medical exoskeleton market is bifurcated into hardware and software. The hardware segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.

In terms of type, the Asia Pacific medical exoskeleton market is bifurcated into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.

Based on extremity, the Asia Pacific medical exoskeleton market is segmented into lower body exoskeleton, upper body exoskeleton, and full body exoskeleton. The lower body exoskeleton segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.

By application, the Asia Pacific medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, stroke, cerebral palsy, Parkinson's Disease, and others. The spinal cord injury segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.

In terms of mobility, the Asia Pacific medical exoskeleton market is bifurcated into mobile exoskeleton and stationary exoskeleton. The powered exoskeleton segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.

By end users, the Asia Pacific medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, long term care centers, homecare settings, and others. The rehabilitation centers segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.

Based on country, the Asia Pacific medical exoskeleton market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Japan segment held the largest share of Asia Pacific medical exoskeleton market in 2023.

BIONIK; B-Temia Inc; Cyberdyne Inc; Ekso Bionics Holdings Inc; ExoAtlet; Hocoma AG; Lifeward, Inc; Myomo Inc; and Rex Bionics Ltd. are some of the leading companies operating in the Asia Pacific medical exoskeleton market.

Product Code: BMIRE00031139

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Medical Exoskeleton Market - Key Market Dynamics

4.1 Medical Exoskeleton Market - Key Market Dynamics
4.2 Market Drivers:
- 4.2.1 Rising Number of Strategic Initiatives
- 4.2.2 Growing Incidence of Stroke and Musculoskeletal
- 4.2.3 Increasing Longevity of Aging Population
4.3 Market Restraints
- 4.3.1 High Cost of Product and Regulatory Concerns
4.4 Market Opportunities
- 4.4.1 Increasing Prevalence of SCI
4.5 Future Trends
- 4.5.1 Increasing Technological Advancements and Rising Investments
4.6 Impact of Drivers and Restraints:

5. Medical Exoskeleton Market - Asia Pacific Analysis

5.1 Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
5.2 Medical Exoskeleton Market Forecast Analysis

6. Medical Exoskeleton Market Analysis - by Component

6.1 Hardware
- 6.1.1 Overview
- 6.1.2 Hardware: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Software
- 6.2.1 Overview
- 6.2.2 Software: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

7. Medical Exoskeleton Market Analysis - by Type

7.1 Powered Exoskeleton
- 7.1.1 Overview
- 7.1.2 Powered Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Passive Exoskeleton
- 7.2.1 Overview
- 7.2.2 Passive Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

8. Medical Exoskeleton Market Analysis - by Extremity

8.1 Lower Body Exoskeleton
- 8.1.1 Overview
- 8.1.2 Lower Body Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Upper Body Exoskeleton
- 8.2.1 Overview
- 8.2.2 Upper Body Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Full Body Exoskeleton
- 8.3.1 Overview
- 8.3.2 Full Body Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

9. Medical Exoskeleton Market Analysis - by Application

9.1 Spinal Cord Injury
- 9.1.1 Overview
- 9.1.2 Spinal Cord Injury: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Multiple Sclerosis
- 9.2.1 Overview
- 9.2.2 Multiple Sclerosis: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Stroke
- 9.3.1 Overview
- 9.3.2 Stroke: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Cerebral Palsy
- 9.4.1 Overview
- 9.4.2 Cerebral Palsy: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Parkinson's Diseases
- 9.5.1 Overview
- 9.5.2 Parkinson's Diseases: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

10. Medical Exoskeleton Market Analysis - by Mobility

10.1 Mobile Exoskeleton
- 10.1.1 Overview
- 10.1.2 Mobile Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Stationary Exoskeleton
- 10.2.1 Overview
- 10.2.2 Stationary Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

11. Medical Exoskeleton Market Analysis - by End Users

11.1 Rehabilitation Centers
- 11.1.1 Overview
- 11.1.2 Rehabilitation Centers: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Physiotherapy Centers
- 11.2.1 Overview
- 11.2.2 Physiotherapy Centers: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Long Term Care Centers
- 11.3.1 Overview
- 11.3.2 Long Term Care Centers: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Homecare Settings
- 11.4.1 Overview
- 11.4.2 Homecare Settings: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

12. Asia Pacific Medical Exoskeleton Market - Country Analysis

12.1 Asia Pacific
- 12.1.1 Asia Pacific Medical Exoskeleton Market Overview
- 12.1.2 Asia Pacific Medical Exoskeleton Market - Revenue and Forecast Analysis - by Country
  - 12.1.2.1 China: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.2.1.1 China: Medical Exoskeleton Market Breakdown, by Component
    - 12.1.2.1.1.1 China: Medical Exoskeleton Market Breakdown, by Hardware
    - 12.1.2.1.1.1.1 China: Medical Exoskeleton Market Breakdown, by Actuators
    - 12.1.2.1.2 China: Medical Exoskeleton Market Breakdown, by Type
    - 12.1.2.1.3 China: Medical Exoskeleton Market Breakdown, by Extremity
    - 12.1.2.1.4 China: Medical Exoskeleton Market Breakdown, by Application
    - 12.1.2.1.5 China: Medical Exoskeleton Market Breakdown, by Mobility
    - 12.1.2.1.6 China: Medical Exoskeleton Market Breakdown, by End Users
  - 12.1.2.2 Japan: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.2.2.1 Japan: Medical Exoskeleton Market Breakdown, by Component
    - 12.1.2.2.1.1 Japan: Medical Exoskeleton Market Breakdown, by Hardware
    - 12.1.2.2.1.1.1 Japan: Medical Exoskeleton Market Breakdown, by Actuators
    - 12.1.2.2.2 Japan: Medical Exoskeleton Market Breakdown, by Type
    - 12.1.2.2.3 Japan: Medical Exoskeleton Market Breakdown, by Extremity
    - 12.1.2.2.4 Japan: Medical Exoskeleton Market Breakdown, by Application
    - 12.1.2.2.5 Japan: Medical Exoskeleton Market Breakdown, by Mobility
    - 12.1.2.2.6 Japan: Medical Exoskeleton Market Breakdown, by End Users
  - 12.1.2.3 India: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.2.3.1 India: Medical Exoskeleton Market Breakdown, by Component
    - 12.1.2.3.1.1 India: Medical Exoskeleton Market Breakdown, by Hardware
    - 12.1.2.3.1.1.1 India: Medical Exoskeleton Market Breakdown, by Actuators
    - 12.1.2.3.2 India: Medical Exoskeleton Market Breakdown, by Type
    - 12.1.2.3.3 India: Medical Exoskeleton Market Breakdown, by Extremity
    - 12.1.2.3.4 India: Medical Exoskeleton Market Breakdown, by Application
    - 12.1.2.3.5 India: Medical Exoskeleton Market Breakdown, by Mobility
    - 12.1.2.3.6 India: Medical Exoskeleton Market Breakdown, by End Users
  - 12.1.2.4 South Korea: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.2.4.1 South Korea: Medical Exoskeleton Market Breakdown, by Component
    - 12.1.2.4.1.1 South Korea: Medical Exoskeleton Market Breakdown, by Hardware
    - 12.1.2.4.1.1.1 South Korea: Medical Exoskeleton Market Breakdown, by Actuators
    - 12.1.2.4.2 South Korea: Medical Exoskeleton Market Breakdown, by Type
    - 12.1.2.4.3 South Korea: Medical Exoskeleton Market Breakdown, by Extremity
    - 12.1.2.4.4 South Korea: Medical Exoskeleton Market Breakdown, by Application
    - 12.1.2.4.5 South Korea: Medical Exoskeleton Market Breakdown, by Mobility
    - 12.1.2.4.6 South Korea: Medical Exoskeleton Market Breakdown, by End Users
  - 12.1.2.5 Australia: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.2.5.1 Australia: Medical Exoskeleton Market Breakdown, by Component
    - 12.1.2.5.1.1 Australia: Medical Exoskeleton Market Breakdown, by Hardware
    - 12.1.2.5.1.1.1 Australia: Medical Exoskeleton Market Breakdown, by Actuators
    - 12.1.2.5.2 Australia: Medical Exoskeleton Market Breakdown, by Type
    - 12.1.2.5.3 Australia: Medical Exoskeleton Market Breakdown, by Extremity
    - 12.1.2.5.4 Australia: Medical Exoskeleton Market Breakdown, by Application
    - 12.1.2.5.5 Australia: Medical Exoskeleton Market Breakdown, by Mobility
    - 12.1.2.5.6 Australia: Medical Exoskeleton Market Breakdown, by End Users
  - 12.1.2.6 Rest of APAC: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.2.6.1 Rest of APAC: Medical Exoskeleton Market Breakdown, by Component
    - 12.1.2.6.1.1 Rest of APAC: Medical Exoskeleton Market Breakdown, by Hardware
    - 12.1.2.6.1.1.1 Rest of APAC: Medical Exoskeleton Market Breakdown, by Actuators
    - 12.1.2.6.2 Rest of APAC: Medical Exoskeleton Market Breakdown, by Type
    - 12.1.2.6.3 Rest of APAC: Medical Exoskeleton Market Breakdown, by Extremity
    - 12.1.2.6.4 Rest of APAC: Medical Exoskeleton Market Breakdown, by Application
    - 12.1.2.6.5 Rest of APAC: Medical Exoskeleton Market Breakdown, by Mobility
    - 12.1.2.6.6 Rest of APAC: Medical Exoskeleton Market Breakdown, by End Users

13. Medical Exoskeleton Market - Industry Landscape

13.1 Overview
13.2 Growth Strategies in Medical Exoskeleton Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Ekso Bionics Holdings Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Lifeward, Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 ExoAtlet
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Cyberdyne Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 BIONIK
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 B-Temia Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Hocoma AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Myomo Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Rex Bionics Ltd.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments

15. Appendix

15.1 About Us
15.2 Glossary of Terms